Skip to main content

News

A study published in Annals of Allergy, Asthma & Immunology found that dupilumab persistence was high after 1 year in adults with atopic dermatitis (AD).
Published in International Journal of Rheumatic Diseases, a study evaluated the relationship of fibromyalgia with enthesopathy, sleep, fatigue, and quality of life in patients with psoriatic arthritis (PsA).
A study published in Annals of the Rheumatic Diseases was conducted to compare the efficacy and safety of brodalumab, an interleukin (IL) 17 receptor subunit A inhibitor, with placebo, in patients with psoriatic arthritis (PsA).
A study published in Dermatology aimed to characterize patients with vs without psoriasis in challenging-to-treat areas seen in routine US clinical practices as they noted real-world studies are limited.
A study published in the International Journal of Dermatology has reported that patients treated with a high dose of intralesional triamcinolone (ILTAC) for hidradenitis suppurativa (HS) have expressed improvements in disease state, quality of life, and overall satisfaction.
A study published in Advances in Therapy that evaluated adults with moderate to severe atopic dermatitis in the United States found a significant link between psychosocial comorbidities and health outcomes.
A study published in New England Journal of Medicine found tirbanibulin was superior to vehicle as a topical treatment for actinic keratoses but was associated with transient localized reactions and recurrence at 1 year.
The use of pneumatic-assisted high velocity jet injections as an alternative method for intradermal delivery of hyaluronic acid may be effective in improving various aesthetic skin concerns.
A prospective, cross-sectional, multicenter study investigated the vascular status of the macula in patients with psoriasis who showed no prior history of ocular inflammation using Optical Coherence Tomography Angiography (OCTA).
Recent assessment has concluded that an increased risk of heart failure is linked to a combination of cardiovascular risk factors as well as onset of disease activity, particularly in nonischemic heart failure.
Back to Top